MitoCLue: High-Throughput Cardiolipin Binding& Mitochondrial Accumulation Assay

Research tools and/or materials

#LIOS-004

SUMMARY

MitoCLue is a novel fluorescent probe that enables 3 complementary cardiolipin (CL) assays – binding affinity measurement, CL quantitative analysis, and CL imaging. Designed for both mitochondrial research and drug safety profiling, MitoCLue supports drug discovery with high-throughput, reproducible and biologically relevant results.

BACKGROUND

Cardiolipin (CL) is a key phospholipid responsible for mitochondrial function and structural integrity. Its depletion is a hallmark of many diseases such as heart failure, diabetes, and aging. While CL is a promising target for mitochondria-specific drugs and drug delivery systems, off-target interactions can cause drugs to accumulate in mitochondria, potentially leading to serious side effects. Until recently, there was no unified assay that would allow to estimate compounds` affinity to CL in a high throughput screening.

FEATURES AND KEY BENEFITS

1. Binding Affinity Assay

Features

  • Validated in 96-well format (Z’ > 0.7), adaptable to 384-well
  • EC₅₀ determination across 6–7 log concentration range
  • Suitable for artificial membranes models or mitoplasts

Benefits

  • Screening of compound libraries for CL binding
  • Facilitates early-stage drug discovery and safety profiling
  • Standard plate reader compatible

2. CL quantitative analysis

Features

  • Direct quantification of CL in isolated mitochondria

Benefits

  • Comparative analysis of CL levels across tissues or conditions

3. CL imaging

Features

  • CL-specific probe suitable for confocal microscopy

Benefits

  • Visualizes mitochondrial distribution and CL-rich zones
  • Non-toxic to cells

REFERENCES

[1] P. Dimitrijevs, P. Arsenyan, Sensors&Actuators B: Chem., 346, 2021, 130537; doi: 10.1016/j.snb.2021.130537 .
[2] P. Dimitrijevs, I. Domracheva, P. Arsenyan, New J. Chem., 2020, 44(23), pp. 9626–9633; doi: 10.1039/D0NJ02116D.
[3] P. Dimitrijevs, et al., Lipids Health Dis. 2025, 24, 76. doi: 10.1186/s12944-025-02499-5.
[4] C. Pegoraro, et al., Adv. Mater. 2025, 37, 2411595; doi: 10.1002/adma.202411595.

AVAILABLE

for licensing, service or research collaboration.

CONTACT

Dr. Anna Stikāne: anna.stikane@osi.lv
Latvian Institute of Organic Synthesis, Aizkraukles Str. 21, Riga LV-1006, Latvia

A. Dose–response curves of cytochrome c, nonyl(triphenyl)phosphonium bromide, and Ca²⁺ demonstrating their relative binding affinities to CL as measured by the MitoCLue assay.
B. Total CL content in mitochondrial fractions isolated from mouse heart, kidney and brain.
C. Confocal microscopy images of a live A2058 cell stained with MitoCLue (green) and Hoechst (Blue).

Back Contact Form